Drug intelligence / Profile preview

Kegan Liyan Oral Solution

Development stage
Phase 3
Lead developer
Guangzhou Wanglaoji Pharmaceutical
Administration
Oral
01

Overview

Kegan Liyan Oral Solution (克感利咽口服液) is a traditional Chinese medicine (TCM) oral liquid formulation developed by Guangzhou Wanglaoji Pharmaceutical. It is composed of 14 herbal ingredients, including *Lonicera japonica* (honeysuckle), *Scutellaria baicalensis* (scutellaria), *Nepeta tenuifolia* (nepeta), *Gardenia jasminoides* (gardenia), *Forsythia suspensa* (forsythia), *Scrophularia ningpoensis* (scrophularia), *Bombyx batryticatus* (processed with ginger), *Rehmannia glutinosa* (rehmannia), *Belamcanda chinensis*, *Platycodon grandiflorus*, *Mentha haplocalyx*, *Periostracum cicadae*, *Saposhnikovia divaricate*, and *Glycyrrhiza uralensis*. It is traditionally used to clear heat, resolve dampness, and relieve sore throat symptoms associated with wind-heat syndrome, such as in acute pharyngitis, influenza, and mild COVID-19. Guangzhou Wanglaoji Pharmaceutical is conducting Phase III clinical trials in China to evaluate its efficacy and safety for acute pharyngitis (wind-heat syndrome).

Brand names
Kegan LiyanKegan Liyan Oral LiquidKegan Liyan Oral Solution克感利咽口服液
Other names
KGLY克感利咽
02

Targets

IL-17A (Interleukin-17A)MMP9 (Matrix metalloproteinase-9)NFKB1 (NF-κB1)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Kegan Liyan Oral Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kegan Liyan Oral Solution.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call